LH · News · 20260804N
Revenue Performance and Mix
LABCORP HOLDINGS INC. · 2026-08-04 · Importance 43 · Surprise 32 · In source text
Labcorp’s Q2 2026 enterprise revenue increased 5.8% year over year to approximately $3.7 billion, or $3,731.1 million. Diagnostics Laboratories and Biopharma Laboratory Services both delivered significant growth during the quarter. Revenue growth was attributed to increased test utilization, specialty testing, price/mix gains, strategic partnerships, and operational efficiencies.
Key facts
- Revenue of $3.73 billion exceeded expectations by $17.55 million with a 5.78% year-over-year increase. source
- Enterprise revenue grew 5.8% to $3.7 billion in Q2 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +0.5% | Revenue of $3.73 billion exceeded expectations by $17.55 million with a 5.78% year-over-year increase. |